Jun 10, 2020

Dissecting antibody-mediated protection against SARS-CoV-2

Nature Reviews. Immunology
Tomer Zohar, Galit Alter

Abstract

No abstract listed.

  • References
  • Citations1

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations1

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

N protein, Severe acute respiratory syndrome virus
Antibody-Dependent Cellular Cytotoxicity
Antibody-Dependent Cellular Cytotoxicity
Antibody-Dependent Cellular Cytotoxicity
Antibody-Dependent Cellular Cytotoxicity
Antibody-Dependent Cellular Cytotoxicity
Antibody-Dependent Cellular Cytotoxicity
Antibody-Dependent Cellular Cytotoxicity
Antibody-Dependent Cellular Cytotoxicity
Antibody-Dependent Cellular Cytotoxicity

Related Feeds

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Related Papers

Current Topics in Microbiology and Immunology
B Corthesy, J P Kraehenbuhl
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Yong XiaDexiong Chen
American Journal of Clinical Pathology
Ahmed BabikerJeannette Guarner
© 2020 Meta ULC. All rights reserved